SEARCH

SEARCH BY CITATION

REFERENCES

  • Ai N, Krasowski MD, Welsh WJ, Ekins S. 2009. Understanding nuclear receptors using computational methods. Drug Discov Today 14:486494. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19429508. Accessed January 28, 2014.
  • Anderson KM, Liao S. 1968. Selective retention of dihydrotestosterone by prostate nuclei. Nature 219:277279.
  • Bruchovsky N, Wilson JD. 1968. The intranuclear binding of testosterone and 5-alpha-androstan-17-beta-ol-3-one by rat prostate. J Biol Chem 243:59535960.
  • Clark JH, Gorski J. 1969. Estrogen-receptors: an evaluation of cytoplasmic-nuclear interactions in a cell-free system, and a method for assay. Biochim Biophys Acta 192:508515.
  • EDSTAC. 1998. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) final report. Available at: http://www.epa.gov/scipoly/oscpendo/pubs/edspoverview/finalrpt.htm. Accessed January, 28, 2014.
  • Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavailles V, Balaguer P. 2006. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem Pharmacol 71:14591469.
  • Fang S, Anderson KM, Laio S. 1969. Receptor proteins for androgens. On the role of specific proteins in selective retention of 17-beta-hydroxy-5-alpha-androstan-3-one by rat ventral prostate in vivo and in vitro. J Biol Chem 244:65846595.
  • Gazdar AF, Oie HK, Shackleton CH, Chen TR, Triche TJ, Myers CE, Chrousos GP, Brennan MF, Stein CA, La Rocca RV. 1990. Cancer Res 50:54885496.
  • Gronemeyer H, Gustafsson JA, Laudet V. 2004. Principles for modulation of the nuclear receptor superfamily. Nat Rev 3:950964.
  • Hecker M, Giesy JP. 2008. Multi-laboratory validation of the H295R steroidogenesis assay to identify modulators of testosterone and estradiol production. Report of Entrix, Inc., Saskatoon SK, Canada. Available at: http://www.epa.gov/endo/pubs/h295r_validation_study_interim_report.pdf. Accessed October 27, 2013.
  • Hecker M, Newsted JL, Murphy MB, Higley EB, Jones PD, Wu R, Giesy JP. 2006a. Human adrenocarcinoma (H295R) cells for rapid in vitro determination of effects on steroidogenesis: hormone production. Toxicol Appl Pharmacol 217(1):114124.
  • Hecker M, Giesy JP, Jones PD, Higley EB, Newsted JL, Mehrle P. 2006b. Influence of cell passage and freeze/thaw events on basal production of 17β-estradiol and testosterone by H295R cells. Interim Draft Report to the U.S.-EPA. Contract code: GS-10F-0041L. September 2006.
  • ICCVAM. 2003. ICCVAM evaluation of in vitro test methods for detecting potential endocrine disruptors: estrogen receptor and androgen receptor binding and transcriptional activation assays. Available at: http://ntp.niehs.nih.gov/?objectid=2BCCBB17-0AE4-6035-AE40845E0CBEBF2E. Accessed January 28, 2014.
  • ICCVAM/NICEATM. 2002. Interagency Coordinating Committee on the Validation of Alternative Methods/National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods. Background review document current status of test methods for detecting endocrine disruptors: in vitro estrogen receptor binding assays. NIH Publication No: 03–4504. http://iccvam.niehs.nih.gov/docs/endo_docs/final1002/erbndbrd/ERBd034504.pdf. Accessed December 4, 2012.
  • Korenman SG. 1970. Relation between estrogen inhibitory activity and binding to cytosol of rabbit and human uterus. Endocrinology 87:11191123.
  • Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139:42524263.
  • Mainwaring WI. 1969a. A soluble androgen receptor in the cytoplasm of rat prostate. J Endocrinol 45:531541.
  • Mainwaring WI. 1969b. The binding of (1,2–3H)testosterone within nuclei of the rat prostate. J Endocrinol 44:13231333.
  • Noteboom W, Gorski J. 1965. Stereospecific binding of estrogens in the rat uterus. Arch Biochem Biophys 111, 559568.
  • Rainey WE, Bird IM, Sawetawan C, Hanley NA, Mccarthy JL, Mcgee EA, Wester R, Mason JI. 1993. Regulation of human adrenal carcinoma cell (NCI-H295) production of C19 steroids. J Clin Endocrinol Metab 77:731737.
  • Sonneveld E, Riteco JA, Jansen HJ, Pieterse B, Brouwer A, Schoonen WG, van der Burg B. 2006. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities. Toxicol Sci 89:173187.
  • Toft D, Shyamala G, Gorski J. 1967. A receptor molecule for estrogens: studies using a cell-free system. Proc Natl Acad Sci USA 57, 17401743.
  • Unhjem O, Tveter KJ. 1969. Localization of an androgen binding substance from the rat ventral prostate. Acta Endocrinol 60:571578.
  • U.S. EPA. 2007. United States Environmental Protection Agency. Aromatase integrated summary report. Available at: http://www.epa.gov/endo/pubs/aromatase_isr.pdf. Accessed January 28, 2014.
  • U.S. EPA. 2009a. Endocrine Disruptor Screening Program Test Guidelines, OPPTS 890.1250: Estrogen receptor binding assay using rat uterine cytosol (ER-RUC). EPA 740-C-09–005.
  • U.S. EPA. 2009b. Endocrine Disruptor Screening Program Test Guidelines, OPPTS 890.1300: Estrogen receptor transcriptional activation (human cell line (HeLa-9903)). EPA 740-C-09–006.
  • U.S. EPA. 2009c. Endocrine Disruptor Screening Program Test Guidelines, OPPTS 890.1150: Androgen receptor binding (rat prostate cytosol). EPA 640-C-09–003.
  • U.S. EPA. 2009d. Endocrine Disruptor Screening Program Test Guidelines, OPPTS 890.1200: Aromatase (human recombinant). EPA 740-C-09–004.
  • U.S. EPA. 2009e. Endocrine Disruptor Screening Program Test Guidelines, OPPTS 890.1550: steroidogenesis (human cell line—H295R). EPA 640-C-09–003.
  • U.S. EPA. 2011. Steroidogenesis (human cell Line—H295R) OCSPP guideline 890.1550. Standard evaluation procedure (SEP). Endocrine Disruptor Screening Program. US Environmental Protection Agency. Washington, DC, July 2011. Available at: http://www.epa.gov/scipoly/oscpendo/pubs/toresources/seps/Final_890.1550_Steroidogenesis_Assay_SEP_8.1.11.pdf. Accessed October 31, 2013.
  • U.S. Federal Register. 2009. [FR Doc No: E9–25352] Notice: endocrine disruptor screening program; Tier 1 screening order issuing announcement. Volume 74, No. 202, Pages 54422–54428. Environmental Protection Agency [EPA-HQ-OPP-2009–0634; FRL-8434–8] October 21, 2009.
  • Zhang Fl, Bartels MJ, Geter DR, Carr MS, McClymount LE, Marino TA, Klecka GM. 2009. Simultaneous quantitation of testosterone, estradiol, ethinyl estradiol, and 11-ketotestosterone in fathead minnow fish plasma by liquid chromatography/positive atmospheric pressure photoionization tandem mass spectrometry. Rapid Commun Mass Spectrom 23:36373646.